Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Wai Chun Bio-Technology Ltd. ( (HK:0660) ) is now available.
Wai Chun Bio-Technology Limited has announced an extension of the Long Stop Date for its Subscription Agreement related to the issuance of new convertible bonds. The extension, agreed upon with the existing bondholder, moves the deadline to 30 September 2025 to allow more time for fulfilling the conditions precedent. This development highlights the company’s ongoing efforts to manage its financial agreements effectively, though it advises caution to shareholders and potential investors as the completion of the subscription remains uncertain.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company is involved in the issuance of convertible bonds and is listed on the Stock Exchange of Hong Kong Limited.
Average Trading Volume: 440,439
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.73M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.